CRA-2059 is a selective and reversible inhibitor of human tryptase beta, exhibiting a Ki value of 620 pM against recombinant human tryptase beta (rHTbeta).
Molecular Weight:
750.82
Purity:
99.29%
CAS Number:
[256649-36-2]
Formula:
C34H46N12O8
Target:
Serine/threonin kinase
T40195
T40195
* VAT and and shipping costs not included. Errors and price changes excepted